Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
An investigation into the use of relaxation therapy as an intervention for hot flushes in women who have had breast cancer
ISRCTN ISRCTN15126436
ClinicalTrials.gov identifier
Public title An investigation into the use of relaxation therapy as an intervention for hot flushes in women who have had breast cancer
Scientific title
Acronym RELAX
Serial number at source N/A
Study hypothesis To test whether relaxation can reduce the incidence and severity of menpausal hot flushes in women with breast cancer.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Breast cancer
Participants - inclusion criteria Patients should:
1. Meet the national HRT study entry criteria
2. Women diagnosed with stage I/II breast cancer with no evidence of recurrence
3. Be postmenopausal (amenorrhoea for >6 months or surgical or radiation ovarian ablation)
4. Be experiencing menopausal hot flushes
5. Able to attend hospital for extra visits
6. Able to complete written records in English
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/12/2000
Anticipated end date 01/01/2001
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Women are randomised to:
1. Control arm: no further treatment
2. Treatment arm: relaxation method
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Cancer Research UK (CRUK) (UK)
Trial website
Publications 2008 results in http://www.ncbi.nlm.nih.gov/pubmed/18359433
Contact name Prof  JL  Corner
  Address Centre for Cancer & Palliative Care Studies
ICR Centre for Cancer & Palliative Care Studies
Fulham Road
Chelsea
  City/town London
  Zip/Postcode SW3 6JJ
  Country United Kingdom
Sponsor Cancer Research UK (CRUK) (UK)
  Address PO Box 123
Lincoln's Inn Fields
  City/town London
  Zip/Postcode WC2A 3PX
  Country United Kingdom
  Tel +44 (0)207 317 5186
  Fax +44 (0)207 487 4302
  Email kate.law@cancer.org.uk
  Sponsor website: http://www.cancer.org.uk
Date applied 15/10/2002
Last edited 21/12/2011
Date ISRCTN assigned 15/10/2002
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central